1. Knowledge Capitalization

Knowledge Capitalization

Connect systems, people and data in a virtual ecosystem to drive innovation and generate competitive advantage

Are you guilty of under-using and under-investing in your most valuable resource?

Harness the collective knowledge of your organization and partners

Win with digital continuity

Business success is driven to a great extent by the creation of new revenue streams (i.e. innovation) and operational excellence. During the last decade, Life Sciences companies have been divided into numerous isolated divisions. To manage this, many created complex matrix-based organizations attempting to enhance cross-division communication and data exchange to streamline internal processes, but much more is required.

Organizations that digitalize their businesses by embracing the principles and technology that deliver digital continuity across the entire innovation continuum will win. This will better serve the drive toward open innovation, research and engineering, manufacturing and the ultimate delivery of differentiated patient experiences. It will transform the way they innovate and operate, driving significantly enhanced margins with patient centric experiences and increased productivity and profits.

Maximize ecosystem engagement to:

Picto > Stakeholders innovation > Dassault Systèmes®
Foster innovation across your enterprise connecting people with the best ideas.
Picto > Business operations > Dassault Systèmes®
Excel in business operations to drive profitability and product quality.
Picto > Patient holistic > Dassault Systèmes®
Increase competitive advantage with disruptive, holistic patient centric experiences.

Connect the best people with the best ideas

Connecting people with data enables quicker, more informed decisions, while infusing virtualization and simulation throughout the development and manufacturing continuum. This helps ensure therapies are produced ‘As designed’ and ‘As registered’ in the most cost-effective and high-quality manner.

The 3DEXPERIENCE® platform enables Life Sciences companies to create experiences to satisfy unmet medical needs and improve patient outcomes in global markets in one virtual environment (exploration, discovery, development, testing, commercialization) – with full visibility across their internal and external ecosystems.

Success story

BMS Drives Higher Quality Science

Bristol-Myers Squibb ELN is a critical first step rather than a magic bullet. Implementing an ELN enables organizations to begin to centralize electronic data and identify legacy tasks and processes that are unnecessary in an electronic workflow.

Life Sciences Industry > Electronic Lab Notebooks > Dassault Systèmes®

"The transition from paper-based systems to electronic ones is the most productive transition we will make as an industry."

Jason Bronfeld
Executive Director, Preclinical and Pharmaceutical Development Informatics Bristol-Myers Squibb

More Life Sciences Challenges